Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
20.48
+0.90 (4.60%)
At close: Feb 6, 2026, 4:00 PM EST
20.16
-0.32 (-1.57%)
After-hours: Feb 6, 2026, 4:42 PM EST
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $1.04 billion as of February 6, 2026. Its market cap has increased by 125.46% in one year.
Market Cap
1.04B
Enterprise Value
749.66M
1-Year Change
125.46%
Ranking
Category
Stock Price
$20.48
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from $740.70M to $1.04B, an increase of 40.11%. That is a compound annual growth rate of 2.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 992.20M | 4.65% |
| Dec 31, 2025 | 948.10M | 104.91% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
| May 16, 2014 | 740.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyePoint | 1.05B |
| Nanobiotix | 1.03B |
| Aktis Oncology | 1.03B |
| Ventyx Biosciences | 1.00B |
| Phathom Pharmaceuticals | 971.64M |
| ORIC Pharmaceuticals | 970.00M |
| Vir Biotechnology | 962.75M |
| UroGen Pharma | 960.05M |